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Fulminant Guillain-Barr  Syndrome Mimicking Cerebral 
Death Following Acute Viral Hepatitis A
Bong-Hui Kang, M.D., Kwang-kuk Kim, M.D., Ph.D.
Department of Neurology, University of Ulsan, Asan Medical Center, Seoul, Korea
A 32-year-old man was transferred to an intensive care unit due to respiratory difficulties with a 4-day history 
of progressive areflexic quadriparesis following acute hepatitis A. A nerve-conduction study revealed inexcitability of 
most nerves. The cerebrospinal fluid showed albuminocytologic dissociation, suggesting Guillain-Barré syndrome 
(GBS). The patient appeared brain dead on day 4, showing absent brainstem reflexes, respiratory failure, and fully 
dilated and fixed pupils. This case is an example of how GBS can evolve and simulate a brain-dead state from 
fulminant deafferentation following acute hepatitis A.
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CASE REPORT
A 32-year-old man was transferred to an intensive 
care unit (ICU) due to respiration difficulties from a 
hepatology ward where he had been admitted after a 
7-day history of symptoms of acute viral hepatitis A 
(HA) and a 3-day history of progressive distal and 
proximal weakness of limbs with additional facial 
weakness. Initial laboratory tests performed at the ward 
(results listed in Table 1) suggested acute viral HA 
infection with high IgM anti-HA antibody titers. Despite 
improvement in liver function and hepatitis symptoms, 
nerve conduction was studied and cerebrospinal fluid 
(CSF) was tapped due to progressive weakness. A 
diagnosis of Guillain-Barré syndrome (GBS) was 
supported by albuminocytologic dissociation (1 white 
blood cell/mm
3, 2 red blood cells/mm
3, 115.0 mg/dL 
protein, and 58 mg/dL glucose) and multiple motor- 
nerve-conduction defects with decreased compound 
motor action potentials (Table 2).
On the second day in the ICU the patient was 
intubated for respiratory arrest and severe autonomic 
fluctuation. His heart rate was 85~120 beats/min and his 
arterial blood pressure was up to 200/110 mmHg. Severe 
diaphoresis was also present. His pupils were dilated to 
5 mm and not reactive to light. On day 4, there were 
no eye movements and spontaneous limb movements 
noted. Neither vertical or horizontal eye movements 
could be elicited. All brainstem reflexes and deep tendon 
reflexes were absent. The results of a CT scan of the 
head were normal. An electroencephalogram exhibited an 
alpha rhythm with reactivity to eye opening. A positive 
pupil response to a 0.1%-pilocarpine test indicated 
ciliary postganglionic parasympathetic neuropathy with 
supersensitivity to acetylcholine. These tests and signs 
indicated the absence of all brain reflexes, suggesting 
the presence of peripheral deafferentation. In addition, Journal of Clinical Neurology: Vol. 3, No. 2, 2007
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Table 1. Data from initial and complementary laboratory tests
Initial laboratory tests Complementary laboratory tests
ALT 981 IU/L (40) HIV Ab/Ag Negative
AST 247 IU/L (40) VDRL Negative
ALP 400 IU/L (120) HSV IgM/IgG Positive 
γ-GT 400 IU/L (63)
¶HSV-1,2/EBV/CMV/Tb PCR Negative
Total bilirubin 10.7 mg/dL (1.2) CMV/EBV PCR Negative
IgM anti-HA  Positive anti-HCV Negative
HBs Ag Negative Rheumatoid factor Negative
HBs Ab Positive Antinuclear factors Negative
¶CSF, another: blood
ALT; alanine aminotrasferase, AST; aspartate aminotrasferase, ALP; Alkaline phosphatase, γ-GT;  γ-glutamyltransferase, HSV; 
herpes simplex virus, EBV; Epstein-Barr virus, CMV; cytomegalovirus, Tb; tuberculosis, HIV; human immunodeficiency virus, 
PCR; polymerase chain reaction, HA; hepatitis A, HBs Ag; hepatitis B surface antigen.
Table 2. Nerve-conduction data
Motor Sensory
Nerve stimulated DML (ms) A (mV) CV (m/s) A (μV)
Day 1
Right median
Right ulnar
Right tibial
Right peroneal
NP
3.5
NP
NP
0.391
42
43
44
46
4.066
12.53
15.05
10.94
Day 14
Right median
Right ulnar
Right tibial
Right peroneal
27.0
12.3
NP
NP
1.1
1.2
NP
NP
NP
NP
DML; distal motor latency, CV; conduction velocity, A; amplitude, NP; no detected potentials.
complementary laboratory tests for vasculitis or other 
infectious agents were normal except for the presence 
of latent herpes simplex virus (HSV) infection. A 
polymerase chain reaction for HSV was negative, and no 
symptoms of HSV infection were detected. A follow-up 
nerve-conduction study performed 2 weeks after transfer 
to the ICU suggested severe demyelinating sensorimotor 
polyneuropathy (Table 2).
Intravenous gammaglobulin (IVIG) (0.4 g/kg/day) was 
administered for 5 days, but his neurological status had 
worsened due to fulminant deafferentation. Therefore, 
pulse therapy with methylprednisolone (500 mg/day) were 
given for 3 days. After the initial 5-day course of 
therapy, IVIG was added twice weekly 2 weeks later. 
The patient gradually recovered and he was weaned off 
the ventilator after 1 month. Three months later he 
recovered complete power in his upper and lower limbs, 
except for a residual deficit of left foot weakness 
(dorsiflexor: grade 4, plantar flexor: grade 4) and 
bilateral hypopathic sensory change of soles.
DISCUSSION
Our patient suffered from fulminant GBS mimicking 
cerebral death following acute viral HA. The develop-
ment of clinical symptoms of hepatitis, marked increases 
in bilirubin, aspartate aminotrasferase, alanine amino-Kang BH, et al. Guillain-Barré Syndrome Mimicking Cerebral Death Following Viral Hepatitis A
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trasferase (ALT), and γ-glutamyltransferase levels, and 
a positive IgM-HA virus antibody test supported the 
diagnosis of acute HA. Cases exhibiting an association 
between GBS and HA are extremely rare.
1 The reported 
clinical features of nine reviewed cases of GBS follow-
ing HA were as follows: (1) a uniformly good outcome 
of the neuropathic symptoms, independent of the level of 
ALT, which corresponds to the severity of liver dys-
function; (2) highest occurrence in men; and (3) the 
interval between the onset of the hepatitis and the 
development of neuropathic symptoms is less than 
14 days.
2  The HSV infection in our patient, in spite of 
neither symptoms nor signs, might have aggravated the 
severity of GBS. 
The initial nerve-conduction study and blink-reflex 
test in this patient revealed inexcitability of most nerves, 
which was due to distal pathology of the motor axons: 
either a distal conduction block or axonal degeneration. 
The nature of this pathology cannot be predicted by the 
results of an initial electrophysiological evaluation.
3 The 
very prolonged distal motor latencies in the electro-
myogram recorded in a subsequent nerve-conduction 
study suggested the presence of severe demyelinating 
polyneuropathy and axonopathy. In the case of GBS 
mimicking cerebral death,
4 a sural nerve biopsy indicated 
that demyelination was the early pathological mechanism. 
Therefore, the exact physiopathology and whether our 
patient had distal demyelination and conduction block 
with secondary axonal loss or axonal degeneration, or 
both, remained unclear. 
The various treatments used for fulminant GBS mi-
micking cerebral death are plasma exchange, IVIG, or 
plasma exchange and corticosteroids.
4 Our patient was 
treated with IVIG to modulate the immunologic reaction, 
and with high-dose pulse therapy with methylpredni-
solone for suppressing the acute severe inflammation in 
the peripheral nervous system. There is no evidence that 
conventional doses of corticosteroids (around 60 mg of 
prednisone daily) are effective in shortening the course 
of or reducing residual deficits in acute GBS.
5 However, 
high-dose steroids are perhaps currently best applied to 
patients who cannot tolerate plasma exchange (e.g., 
due to severe cardiovascular dysautonomia) or when 
other treatments are unavailable.
6–8
Our patient recovered progressively, and could walk 
alone with mild weakness of the left foot at 3 months 
after admission. GBS mimicking brain death usually has 
a poor recovery rate and a high mortality, particularly 
in relation to dysautonomia.
9 The timely application 
of combination pulse therapy with both IVIG and 
methylprednisolone might improve the prognosis of 
fulminant GBS.
In summary, in rare cases GBS presents with signs of 
coma and absent brainstem reflexes. The present case 
may represent the first report of fulminant GBS follow-
ing acute HA. 
REFERENCES
 1. Mares-Segura R, Sola-Lamoglia R, Soler-Singla L, Pou- 
Serradell A. Guillain-Barré syndrome associated with 
hepatitis A. Ann Neurol 1986;19:100.
 2. Ono S, Chida K, Takasu T. Guillain-Barré syndrome 
following fulminant viral hepatitis A. Intern Med 1994;33: 
799-801.
 3. Triggs WJ, Cros D, Gominak SC, Zuniga G, Beric A, 
Shahani BT, et al. Motor nerve inexcitability in Guillain- 
Barré syndrome. The spectrum of distal conduction block 
and axonal degeneration. Brain  1992;115:1291-1302.
 4. Vargas F, Hilbert G, Gruson D, Valentino R, Gbikpi- 
Benissan G, Cardinaud JP. Fulminant Guillain-Barré 
syndrome mimicking cerebral death: case report and lite-
rature review. Intensive Care Med 2000;26:623-627.
 5. Samantray SK, Johnson SC, Mathai KV, Pulimood BM. 
Landry-Guillain-Barré-Strohl syndrome. A study of 302 
cases.  Med J Aust 1977;2:84-91.
 6. Dowling PC, Bosch VV, Cook SD. Possible beneficial 
effect of high-dose intravenous steroid therapy in acute 
demyelinating disease and transverse myelitis. Neurology 
1980;3033-36.
 7. Mori E, Yoshida T, Ohsumi Y, Tabuchi M, Yamadori A. 
Beneficial effects of plasma exchange in acute Guillain- 
Barré syndrome: comparision with methylprednisolone pulse 
therapy.  Clin Neurol 1988;28;196-203.
 8. Ropper AH, Wijdicks EF, Truax BT. Guillain-Barré synd-
rome. Contemporary Neurology Series. Philadelphia: F.A. 
Davis; 1991;232-234.
 9. Winer JB, Hughes RA, Greenwood RJ, Perkin GD, Healy 
MJ. Prognosis in Guillain-Barré syndrome. Lancet 1985;1: 
1202-1203.